glp 1 agonist perioperative GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the setting. These Endoscopy & GLP-1 Receptor Agonists

Description

However, long-term studies on GLP-1RAs exposure indicate no significant changes in the risks of thyroid, bladder, or pancreatic cancers, whereas the incidence of prostate, lung, and colorectal cancers has been shown to significantly decrease [20]

some of the study period preceded the approval of semaglutide and tirzepatide to treat obesity

149 It is important to note that while there is evidence suggesting the potential benefits of using DPP4 inhibitors for COVID-19, further research and clinical trials are needed to establish their effectiveness and safety in this specific context

By modulating these physiological processes, this product assists individuals in consuming fewer calories, which can result in sustainable weight loss